Oleksandr A. Pishchurin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oleksandr A. Pishchurin has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Volodymyr V. Isaienko
National Amosov Institute of cardiovascular surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
5 shared publications - Dmytro N. Dyadyun
ДУ «Національний науковий центр серцево-судинної хірургії та спадкової патології ім. М.М. Амосова НАМН України», Київ, Україна
4 shared publications - Rostyslav M. Vitovskyi
National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine; Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
4 shared publications - Volodymyr F. Onishchenko
Національний університет охорони здоров’я України імені П.Л. Шупика, Київ, Україна
4 shared publications - Maryna M. Serdiuk
National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
3 shared publications - Valentina P. Zakharova
National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
3 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Chetverta Khvylia in Ukrainian Heart Journal
- Vol. 15 (2) , 39-47
Хірургічні доступи при видаленні пухлин серця: значення вибору для радикальності й безпечності оперативного втручання
Cardiac tumors are rare but clinically significant conditions requiring surgical treatment. The radicality of tumor resection and prevention of recurrence largely depend on the appropriate choice of surgical access. Adequate visualization of the tumor implantation site and complete inspection of cardiac chambers determine both early and long-term outcomes.The aim – to optimize the selection of surgical approaches in the operative treatment of cardiac tumors based on one-center long-term clinical experience.Materials and methods. We retrospectively analyzed 1,061 patients who underwent surgical treatment for cardiac tumors between 1969 and 2026. Cardiac myxomas accounted for 948 (89.3%) cases, non-myxomatous benign tumors for 42 (4.1%), and malignant tumors for 71 (6.7%). Surgical approaches were evaluated according to tumor morphology, localization, and extent, as well as their impact on radical resection and recurrence rates.Results. In patients with left atrial myxomas, the transseptal approach via right atriotomy demonstrated the lowest rate of tumor fragmentation (21.2%) compared to the direct left atrial approach (39.5%) and allowed complete inspection of the interatrial septum. The overall recurrence rate of myxomas was 1.2% when radical resection principles were followed. For non-myxomatous tumors of valvular and intraventricular localization, combined and video-assisted approaches proved effective in achieving safe and precise tumor removal. In 98.6% of malignant tumor cases, median sternotomy was performed, with individualized cardiopulmonary bypass strategies and extended exposure of great vessels when required.Conclusions. A choice of surgical access is a decisive factor in achieving radical resection of cardiac tumors and preventing recurrence. For left atrial myxomas, the transseptal approach via right atriotomy provides optimal visualization of the implantation site and reduces the risk of residual tumor tissue. In non-myxomatous and malignant tumors, individualized access selection based on tumor localization and extent ensures oncological radicality and procedural safety.
- 30 August 2026
- Published by Chetverta Khvylia in Ukrainian Heart Journal
- Vol. 15 (2) , 39-47
Open AccessХірургічні доступи при видаленні пухлин серця: значення вибору для радикальності й безпечності оперативного втручання
Cardiac tumors are rare but clinically significant conditions requiring surgical treatment. The radicality of tumor resection and prevention of recurrence largely depend on the appropriate choice of surgical access. Adequate visualization of the tumor implantation site and complete inspection of cardiac chambers determine both early and long-term outcomes.The aim – to optimize the selection of surgical approaches in the operative treatment of cardiac tumors based on one-center long-term clinical experience.Materials and methods. We retrospectively analyzed 1,061 patients who underwent surgical treatment for cardiac tumors between 1969 and 2026. Cardiac myxomas accounted for 948 (89.3%) cases, non-myxomatous benign tumors for 42 (4.1%), and malignant tumors for 71 (6.7%). Surgical approaches were evaluated according to tumor morphology, localization, and extent, as well as their impact on radical resection and recurrence rates.Results. In patients with left atrial myxomas, the transseptal approach via right atriotomy demonstrated the lowest rate of tumor fragmentation (21.2%) compared to the direct left atrial approach (39.5%) and allowed complete inspection of the interatrial septum. The overall recurrence rate of myxomas was 1.2% when radical resection principles were followed. For non-myxomatous tumors of valvular and intraventricular localization, combined and video-assisted approaches proved effective in achieving safe and precise tumor removal. In 98.6% of malignant tumor cases, median sternotomy was performed, with individualized cardiopulmonary bypass strategies and extended exposure of great vessels when required.Conclusions. A choice of surgical access is a decisive factor in achieving radical resection of cardiac tumors and preventing recurrence. For left atrial myxomas, the transseptal approach via right atriotomy provides optimal visualization of the implantation site and reduces the risk of residual tumor tissue. In non-myxomatous and malignant tumors, individualized access selection based on tumor localization and extent ensures oncological radicality and procedural safety.
- 29 July 2026
- Published by LLC MORION in Ukrainian Medical Journal
Питання діагностики, хірургічної тактики лікування та післяопераційного ведення пацієнтів зі злоякісними пухлинами серця
Частота виявлення пухлин серця (ПС) становить 0,5 випадка на 1 млн населення, крім того, 10% серед них становлять злоякісні пухлини серця (ЗПС). Шпитальна летальність пацієнтів із ЗПС становить 20–50%. Мета дослідження: визначити оптимальну діагностично-хірургічну тактику при ЗПС на основі багаторічного одноцентрового досвіду, з урахуванням радикальності видалення пухлини, необхідності реконструкції уражених структур серця та профілактики інтраопераційних і ранніх післяопераційних ускладнень. Об’єкт і методи дослідження. У Національному науковому центрі серцево-судинної хірургії та спадкової патології ім. М.М. Амосова НАМН України за період з 01.01.1969 до 01.01.2026 р. прооперовано 1061 пацієнта з ПС. Неміксоматозні доброякісні ПС виявили в 42 (4,1%), ЗПС — в 71 (6,7%) випадку. Вік хворих з ПС коливався в межах 3–80 років (в середньому 49,4±3,4 року). Серед хворих із ЗПС виявилося 36 жінок (50,8%). Результати. Із 71 виконаної операції 61 (85,9%) проведено з використанням штучного кровообігу, з яких 24 (33,8%) умовно радикальні кардіохірургічні втручання з хорошим гемодинамічним ефектом. Задля виконання максимально радикального видалення новоутворення в 31 (43,7%) випадку використано додаткові хірургічні маніпуляції, що включали пластику міжпередсердної перегородки, стінок передсердь, пластичні корекції клапанних пошкоджень, а також протезування серцевих клапанів. Шпитальна летальність при хірургічному лікуванні становила 18,3% (13 хворих). Розроблено та застосовано схему дезінтоксикаційних заходів на операційному та ранньому післяопераційному етапах, завдяки чому вдалося знизити шпитальну летальність з 33,3% (1970–2003 рр.) до 4,8% за останні 20 років (2004–2025 рр.). Висновки. Діагностика ЗПС ускладнюється поліморфізмом характеру перебігу та локалізації, що в більшості випадків призводить до запізнілого виявлення та шпиталізації цих пацієнтів у кардіохірургічні центри. При хірургічному лікуванні ЗПС для досягнення максимального гемодинамічного ефекту часто (43,7%) необхідне застосування розширених методик реконструкцій ушкоджених структур серця, а також проведення дезінтоксикаційних профілактичних заходів як в інтраопераційний, так і в ранній післяопераційний період у цієї когорти пацієнтів, що знижує летальність з 33,3 до 4,8%. Тривалість виживаності пацієнтів після видалення ЗПС забезпечується невідкладним проведенням адекватної хімієтерапії в ранній післяопераційний період, що не дає можливості активізуватися метастазам, які найчастіше є причиною смерті цих хворих після хірургічного лікування.
- 29 July 2026
- Published by LLC MORION in Ukrainian Medical Journal
Питання діагностики, хірургічної тактики лікування та післяопераційного ведення пацієнтів зі злоякісними пухлинами серця
Частота виявлення пухлин серця (ПС) становить 0,5 випадка на 1 млн населення, крім того, 10% серед них становлять злоякісні пухлини серця (ЗПС). Шпитальна летальність пацієнтів із ЗПС становить 20–50%. Мета дослідження: визначити оптимальну діагностично-хірургічну тактику при ЗПС на основі багаторічного одноцентрового досвіду, з урахуванням радикальності видалення пухлини, необхідності реконструкції уражених структур серця та профілактики інтраопераційних і ранніх післяопераційних ускладнень. Об’єкт і методи дослідження. У Національному науковому центрі серцево-судинної хірургії та спадкової патології ім. М.М. Амосова НАМН України за період з 01.01.1969 до 01.01.2026 р. прооперовано 1061 пацієнта з ПС. Неміксоматозні доброякісні ПС виявили в 42 (4,1%), ЗПС — в 71 (6,7%) випадку. Вік хворих з ПС коливався в межах 3–80 років (в середньому 49,4±3,4 року). Серед хворих із ЗПС виявилося 36 жінок (50,8%). Результати. Із 71 виконаної операції 61 (85,9%) проведено з використанням штучного кровообігу, з яких 24 (33,8%) умовно радикальні кардіохірургічні втручання з хорошим гемодинамічним ефектом. Задля виконання максимально радикального видалення новоутворення в 31 (43,7%) випадку використано додаткові хірургічні маніпуляції, що включали пластику міжпередсердної перегородки, стінок передсердь, пластичні корекції клапанних пошкоджень, а також протезування серцевих клапанів. Шпитальна летальність при хірургічному лікуванні становила 18,3% (13 хворих). Розроблено та застосовано схему дезінтоксикаційних заходів на операційному та ранньому післяопераційному етапах, завдяки чому вдалося знизити шпитальну летальність з 33,3% (1970–2003 рр.) до 4,8% за останні 20 років (2004–2025 рр.). Висновки. Діагностика ЗПС ускладнюється поліморфізмом характеру перебігу та локалізації, що в більшості випадків призводить до запізнілого виявлення та шпиталізації цих пацієнтів у кардіохірургічні центри. При хірургічному лікуванні ЗПС для досягнення максимального гемодинамічного ефекту часто (43,7%) необхідне застосування розширених методик реконструкцій ушкоджених структур серця, а також проведення дезінтоксикаційних профілактичних заходів як в інтраопераційний, так і в ранній післяопераційний період у цієї когорти пацієнтів, що знижує летальність з 33,3 до 4,8%. Тривалість виживаності пацієнтів після видалення ЗПС забезпечується невідкладним проведенням адекватної хімієтерапії в ранній післяопераційний період, що не дає можливості активізуватися метастазам, які найчастіше є причиною смерті цих хворих після хірургічного лікування.
- Open Access
- 25 December 2025
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (4)
Papillary Fibroelastoma of the Heart: Controversies in Histogenesis, Detection, and Surgical Strategy
Background. Papillary fibroelastoma (PFE) is a small endocardial tumor, typically located on heart valves, with a disproportionately high embolic risk. Despite classic echocardiographic descriptions, debate continues regarding its origin (reactive vs. “thrombo-endothelial,” potentially arising from Lambl’s excrescences), the indications for surgery in asymptomatic patients, and the role of minimally invasive or percutaneous resection. Aim. To analyse the prevalence and characteristics of PFE among cardiac tumors based on our institutional experience and current literature, to address controversial aspects, and to outline surgical strategies according to neoplasm localization. Materials and Methods. Between 1969 and 2025, 1046 patients with cardiac tumors underwent surgery at the Amosov National Institute of Cardiovascular Surgery (Kyiv, Ukraine). Myxomas accounted for 89.4 % of benign cardiac tumors, while PFE accounted for 1.3 % of all cases and 34.2 % of non-myxomatous benign tumors. Results Most PFEs were valvular, predominantly located in the aortic and mitral positions. Although frequently asymptomatic, they were associated with embolic events. Surgical “shave excision” with valve preservation enabled complete resection with minimal morbidity. In large series (Mayo Clinic and other centres), surgical outcomes are excellent; however, recent data show a significantly higher long-term recurrence rate for aortic PFEs than previously reported, reaching 15-16 % over 10 years, underscoring the need for prolonged echocardiographic follow-up [13]. Percutaneous ablation is emerging as an option for selected asymptomatic patients, though robust evidence remains limited. Conclusions. PFE is a small but clinically significant tumor with serious embolic potential. Optimal management includes timely recognition, valve-sparing surgical excision, and structured postoperative surveillance. Further studies are needed to clarify its histogenesis, establish operative thresholds for asymptomatic patients, and define the role of percutaneous interventions.
- 25 December 2025
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (4)
Open AccessPapillary Fibroelastoma of the Heart: Controversies in Histogenesis, Detection, and Surgical Strategy
Background. Papillary fibroelastoma (PFE) is a small endocardial tumor, typically located on heart valves, with a disproportionately high embolic risk. Despite classic echocardiographic descriptions, debate continues regarding its origin (reactive vs. “thrombo-endothelial,” potentially arising from Lambl’s excrescences), the indications for surgery in asymptomatic patients, and the role of minimally invasive or percutaneous resection. Aim. To analyse the prevalence and characteristics of PFE among cardiac tumors based on our institutional experience and current literature, to address controversial aspects, and to outline surgical strategies according to neoplasm localization. Materials and Methods. Between 1969 and 2025, 1046 patients with cardiac tumors underwent surgery at the Amosov National Institute of Cardiovascular Surgery (Kyiv, Ukraine). Myxomas accounted for 89.4 % of benign cardiac tumors, while PFE accounted for 1.3 % of all cases and 34.2 % of non-myxomatous benign tumors. Results Most PFEs were valvular, predominantly located in the aortic and mitral positions. Although frequently asymptomatic, they were associated with embolic events. Surgical “shave excision” with valve preservation enabled complete resection with minimal morbidity. In large series (Mayo Clinic and other centres), surgical outcomes are excellent; however, recent data show a significantly higher long-term recurrence rate for aortic PFEs than previously reported, reaching 15-16 % over 10 years, underscoring the need for prolonged echocardiographic follow-up [13]. Percutaneous ablation is emerging as an option for selected asymptomatic patients, though robust evidence remains limited. Conclusions. PFE is a small but clinically significant tumor with serious embolic potential. Optimal management includes timely recognition, valve-sparing surgical excision, and structured postoperative surveillance. Further studies are needed to clarify its histogenesis, establish operative thresholds for asymptomatic patients, and define the role of percutaneous interventions.
- Open Access
- 25 March 2025
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (1) , 67-76
Tricuspid Valve Myxoma: Features of Anatomy, Clinical Course, and Surgical Treatment
Relevance. Myxomas originating from the tricuspid valve (TV) are extremely rare. The literature describes myxomas that most often affect one leaflet of the TV. For the first time in our extensive practice, we encountered a myxoma of the right heart, which incredibly affected all leaflets of the tricuspid valve, which left no chance for its preservation. Aim. To present our experience in treating TV lesions in cardiac myxomas with a demonstration of a rare case of myxoma of probably congenital nature that affected all of its leaflets. Materials and methods. Among 922 patients with cardiac myxomas (CM), 70 (7.6%) patients with heart valve lesions due to this tumor were identified. The article presents the experience in treating tricuspid valve lesions in CM and a case of diagnosis and surgical treatment of TV myxoma of unusual localization in a 71-year-old woman. Diagnosis based on the use of echocardiography, coronary angiography and laboratory methods. Results. Isolated tricuspid valve insufficiency was observed in 30 patients. However, only 9 of these patients had a direct effect of myxoma on the function of the valve, which was located in the cavity of the right atrium (8) and right ventricle (1). In one case, a myxoma measuring 3.0×2.5 cm in a capsule with a smooth surface was found in the hole of the TV. The base of the tumor was located on the fibrous ring of the TV at the point of transition of the posterior leaflet into the septal with the involvement of all leaflets and all chords of this valve, which were included in the body of the tumor. The valve is significantly distorted with the inability to differentiate its leaflets. The tumor does not visually spread beyond the leaflets and fibrous ring. Given the very unusual location with an extremely unfavorable prognosis, the patient underwent surgery to remove the tumor and replacement the tricuspid valve. Conclusions. Myxomas of the ventricular septum are very unusual tumors with a diverse and unpredictable pattern of lesions that can be detected after the onset of symptomatic ventricular septum obstruction and signs of right ventricular heart failure. Despite significant lesions of the ventricular septum by a tumor process of a likely congenital nature, there is a possibility of a long asymptomatic course of the disease. Surgical treatment of TV myxoma involves removing the tumor with a high probability of replacing the affected valve.
- 25 March 2025
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- Vol. 33 (1) , 67-76
Open AccessTricuspid Valve Myxoma: Features of Anatomy, Clinical Course, and Surgical Treatment
Relevance. Myxomas originating from the tricuspid valve (TV) are extremely rare. The literature describes myxomas that most often affect one leaflet of the TV. For the first time in our extensive practice, we encountered a myxoma of the right heart, which incredibly affected all leaflets of the tricuspid valve, which left no chance for its preservation. Aim. To present our experience in treating TV lesions in cardiac myxomas with a demonstration of a rare case of myxoma of probably congenital nature that affected all of its leaflets. Materials and methods. Among 922 patients with cardiac myxomas (CM), 70 (7.6%) patients with heart valve lesions due to this tumor were identified. The article presents the experience in treating tricuspid valve lesions in CM and a case of diagnosis and surgical treatment of TV myxoma of unusual localization in a 71-year-old woman. Diagnosis based on the use of echocardiography, coronary angiography and laboratory methods. Results. Isolated tricuspid valve insufficiency was observed in 30 patients. However, only 9 of these patients had a direct effect of myxoma on the function of the valve, which was located in the cavity of the right atrium (8) and right ventricle (1). In one case, a myxoma measuring 3.0×2.5 cm in a capsule with a smooth surface was found in the hole of the TV. The base of the tumor was located on the fibrous ring of the TV at the point of transition of the posterior leaflet into the septal with the involvement of all leaflets and all chords of this valve, which were included in the body of the tumor. The valve is significantly distorted with the inability to differentiate its leaflets. The tumor does not visually spread beyond the leaflets and fibrous ring. Given the very unusual location with an extremely unfavorable prognosis, the patient underwent surgery to remove the tumor and replacement the tricuspid valve. Conclusions. Myxomas of the ventricular septum are very unusual tumors with a diverse and unpredictable pattern of lesions that can be detected after the onset of symptomatic ventricular septum obstruction and signs of right ventricular heart failure. Despite significant lesions of the ventricular septum by a tumor process of a likely congenital nature, there is a possibility of a long asymptomatic course of the disease. Surgical treatment of TV myxoma involves removing the tumor with a high probability of replacing the affected valve.
- Open Access
- 26 December 2022
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 30 (4) , 122-127
Features of the Blood Supply of Cardiac Myxoma which Can Cause Bleeding
With a mortality rate of 1 % to 5 %, surgical treatment of cardiac myxomas (CM) may be complicated by the development of intra- or postoperative bleeding, among other things. The aim. To present an unusual case of surgical treatment of left atrial myxoma with the occurrence of intraoperative bleeding, which was due to extremely rare features of the coronary circulation with a special blood supply to the base of the CM. Case report. Female patient R., 65 years old, case record No.3686, was admitted to the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine with diagnosis of CM. Coronary angiography revealed unique features of coronary circulation: an arteriovenous malformation from the distal parts of the circumflex branch of the left coronary artery with discharge into the right parts of the heart was revealed. On 9/20/2022, urgent operation of resection of the myxoma of the left atrium (LA) was performed. After removal of the myxoma and sealing of the heart, accumulation of arterial blood was found in the area of the inferior vena cava (IVC) and the interatrialsulcus. Revision of the left atrium cavity was performed again:all intracardiac sutures in the area of the myxoma base were duplicated. After repeated resealing of the heart chambers, bleeding from the IVC region stopped after administration of protamine sulfate and tight tamponade of the space under the IVC. Tampons were removed from the pericardial cavity after 72 hours. Results. The source of the bleeding could be the site of the malformation of the coronary arteries, which is a tangle of small vessels located in the projection of the base of the myxoma below the point where the IVC meets the right atrium. During the histological examination of the myxoma, large full-blood vessels of the sinusoidal type were revealed, around which, due to damage to their thin walls, hematomas formed, giving the tumor a spotted appearance. The peculiarity of this tumor was the presence of a very large vascular plexus at its base; it had the appearance of a cluster of sections of numerous, different-sized, deformed and remodeled arteries. These data were confirmed by coronary angiography. Conclusions. Studying the data of coronary angiography with the analysis offeatures of localization of coronary arteries, as well as the presence of possible coronary malformations, can provide information that allows predicting the possibility of their damage, especially in the case of localization in the place of possible surgical manipulation. In the event of bleeding, one of the optimal methods of its elimination is the use of long-term tamponade.
- 26 December 2022
- Published by Professional Edition Eastern Europe in Ukrainian journal of cardiovascular surgery
- Vol. 30 (4) , 122-127
Open AccessFeatures of the Blood Supply of Cardiac Myxoma which Can Cause Bleeding
With a mortality rate of 1 % to 5 %, surgical treatment of cardiac myxomas (CM) may be complicated by the development of intra- or postoperative bleeding, among other things. The aim. To present an unusual case of surgical treatment of left atrial myxoma with the occurrence of intraoperative bleeding, which was due to extremely rare features of the coronary circulation with a special blood supply to the base of the CM. Case report. Female patient R., 65 years old, case record No.3686, was admitted to the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine with diagnosis of CM. Coronary angiography revealed unique features of coronary circulation: an arteriovenous malformation from the distal parts of the circumflex branch of the left coronary artery with discharge into the right parts of the heart was revealed. On 9/20/2022, urgent operation of resection of the myxoma of the left atrium (LA) was performed. After removal of the myxoma and sealing of the heart, accumulation of arterial blood was found in the area of the inferior vena cava (IVC) and the interatrialsulcus. Revision of the left atrium cavity was performed again:all intracardiac sutures in the area of the myxoma base were duplicated. After repeated resealing of the heart chambers, bleeding from the IVC region stopped after administration of protamine sulfate and tight tamponade of the space under the IVC. Tampons were removed from the pericardial cavity after 72 hours. Results. The source of the bleeding could be the site of the malformation of the coronary arteries, which is a tangle of small vessels located in the projection of the base of the myxoma below the point where the IVC meets the right atrium. During the histological examination of the myxoma, large full-blood vessels of the sinusoidal type were revealed, around which, due to damage to their thin walls, hematomas formed, giving the tumor a spotted appearance. The peculiarity of this tumor was the presence of a very large vascular plexus at its base; it had the appearance of a cluster of sections of numerous, different-sized, deformed and remodeled arteries. These data were confirmed by coronary angiography. Conclusions. Studying the data of coronary angiography with the analysis offeatures of localization of coronary arteries, as well as the presence of possible coronary malformations, can provide information that allows predicting the possibility of their damage, especially in the case of localization in the place of possible surgical manipulation. In the event of bleeding, one of the optimal methods of its elimination is the use of long-term tamponade.
- Open Access
- 18 June 2021
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- No. 2 (43),p. 35-41
The Question of Relapse of a Cardiac Myxoma: an Unusual Case from Practice
Various studies demonstrate that recurrence of cardiac myxoma (CM) occurs in 2.1–5.3% of cases. In cases of treatment of familial myxoma, the need for reoperations can reach 20–25%. It should be taken into account that among all benign cardiac tumors, CM is detected in up to 80% of cases, and the need for its surgical removal is beyond doubt. The aim. To present a case that is of particular interest due to an unusual multiple myxomas lesion of the heart of multi-chamber localization. Material and methods. This article presents an unusual case of detecting multiple myxomas of multi-cameral heart lesions 6 years after removal of myxoma of the left atrium of typical localization. The distinguishing feature of the course of the disease lies in the fact that in this case, a careful study of the life history did not reveal the characteristic signs of familial myxomas and Carney complex which is most often characteristic of multi-chamber lesions of the heart by a tumor process. At the same time, during the surgical removal of the myxoma of the left ventricle, the myxomas of the left and right atrium were revealed, which began to grow. A technical feature of the removal of the left ventricular myxoma of the apical localization was the use of video cameras and instruments for thoracoscopic surgery, which greatly facilitated revi-sion and removal of the hard-to-reach neoplasm. Our experience in surgical treatment of CM equals to 868 operations. Wherein, repeated operations performed in 12 patients were due to recurrence or appearance of a tumor in place other than the primary localization. Conclusions. CM recurrence is one of infrequent complications in the postoperative period, which, however, requires some vigilance and annual Echo monitoring. In the vast majority of cases, CM was represented by the so-called sporadic myxomas, which are more often localized in the left atrium, and rarely recur. If CM is suspected, it is necessary to exclude the possibility of “myxoma syndrome”, which has the frequency of 0.8%, according to our data. The use of the instruments for thoracoscopic surgery can greatly facilitate the removal of hard-to-reach heart tumors localization.
- 18 June 2021
- Published by National Institute of Cardiovascular Surgery named after M.M. Amosov of the NAMS of Ukraine in Ukrainian journal of cardiovascular surgery
- No. 2 (43),p. 35-41
Open AccessThe Question of Relapse of a Cardiac Myxoma: an Unusual Case from Practice
Various studies demonstrate that recurrence of cardiac myxoma (CM) occurs in 2.1–5.3% of cases. In cases of treatment of familial myxoma, the need for reoperations can reach 20–25%. It should be taken into account that among all benign cardiac tumors, CM is detected in up to 80% of cases, and the need for its surgical removal is beyond doubt. The aim. To present a case that is of particular interest due to an unusual multiple myxomas lesion of the heart of multi-chamber localization. Material and methods. This article presents an unusual case of detecting multiple myxomas of multi-cameral heart lesions 6 years after removal of myxoma of the left atrium of typical localization. The distinguishing feature of the course of the disease lies in the fact that in this case, a careful study of the life history did not reveal the characteristic signs of familial myxomas and Carney complex which is most often characteristic of multi-chamber lesions of the heart by a tumor process. At the same time, during the surgical removal of the myxoma of the left ventricle, the myxomas of the left and right atrium were revealed, which began to grow. A technical feature of the removal of the left ventricular myxoma of the apical localization was the use of video cameras and instruments for thoracoscopic surgery, which greatly facilitated revi-sion and removal of the hard-to-reach neoplasm. Our experience in surgical treatment of CM equals to 868 operations. Wherein, repeated operations performed in 12 patients were due to recurrence or appearance of a tumor in place other than the primary localization. Conclusions. CM recurrence is one of infrequent complications in the postoperative period, which, however, requires some vigilance and annual Echo monitoring. In the vast majority of cases, CM was represented by the so-called sporadic myxomas, which are more often localized in the left atrium, and rarely recur. If CM is suspected, it is necessary to exclude the possibility of “myxoma syndrome”, which has the frequency of 0.8%, according to our data. The use of the instruments for thoracoscopic surgery can greatly facilitate the removal of hard-to-reach heart tumors localization.
- Open Access
- 1 February 2021
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- No. 1,p. 13-23
Valve dysfunction in patients with cardiac myxomas: mechanism of damage and methods of correction
The aim – to analyze the frequency and nature of lesions of the valve apparatus, to evaluate the results of surgical correction of the affected valves in heart myxomas. Materials and methods. In one-centre study, during period from 01.01.1969 to 01.10.2020, 962 patients with morphologically verified primary heart tumors were observed. Myxomas of the heart were found in 856 (89.0 %) patients. The pathology of the valve apparatus in combination with cardiac myxomas was noted in 70 (8.1 %) patients. The volume and nature of valve damage differed and depended on size, consistency and localization of myxoma, the degree of its mobility, and the presence of areas of pronounced fibrosis and calcification on the tumor. Results. Surgical correction of lesions of valve structures was performed in 65 patients. In 5 patients, it was possible to remove tumor tissue from the valve apparatus, followed by prevention of disease recurrence without damaging valve and subvalvular structures. Surgical techniques included both plastic manipulation and valve replacement. The features of the long-term postoperative period in such patients include progressive valve dysfunction manifested by the progression of insufficiency due to further deformation of the valve apparatus. Conclusions. Alongside with myxoma removal, it is necessary to conduct a thorough examination of the valve apparatus and correction of valve damage by various methods, including plastic surgery and valve replacement, depending on the nature and severity of the damage. Key words: cardiac tumors, myxoma, valve structures, surgical treatment.
- 1 February 2021
- Published by Chetverta Khvylia in Cardiac Surgery and Interventional Cardiology
- No. 1,p. 13-23
Open AccessValve dysfunction in patients with cardiac myxomas: mechanism of damage and methods of correction
The aim – to analyze the frequency and nature of lesions of the valve apparatus, to evaluate the results of surgical correction of the affected valves in heart myxomas. Materials and methods. In one-centre study, during period from 01.01.1969 to 01.10.2020, 962 patients with morphologically verified primary heart tumors were observed. Myxomas of the heart were found in 856 (89.0 %) patients. The pathology of the valve apparatus in combination with cardiac myxomas was noted in 70 (8.1 %) patients. The volume and nature of valve damage differed and depended on size, consistency and localization of myxoma, the degree of its mobility, and the presence of areas of pronounced fibrosis and calcification on the tumor. Results. Surgical correction of lesions of valve structures was performed in 65 patients. In 5 patients, it was possible to remove tumor tissue from the valve apparatus, followed by prevention of disease recurrence without damaging valve and subvalvular structures. Surgical techniques included both plastic manipulation and valve replacement. The features of the long-term postoperative period in such patients include progressive valve dysfunction manifested by the progression of insufficiency due to further deformation of the valve apparatus. Conclusions. Alongside with myxoma removal, it is necessary to conduct a thorough examination of the valve apparatus and correction of valve damage by various methods, including plastic surgery and valve replacement, depending on the nature and severity of the damage. Key words: cardiac tumors, myxoma, valve structures, surgical treatment.
- Open Access
- 30 January 2019
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 85 (1) , 17-20
Вопросы радикальности хирургического лечения злокачественных опухолей сердца
Цель. Определить методы диагностики и хирургического лечения, направленные на максимально радикальное удаление злокачественной опухоли сердца. Материалы и методы. В Институте сердечно-сосудистой хирургии имени Н. М. Амосова НАМН Украины с 1970 по 01.01.2018 г. проведено лечение 912 пациентам с опухолями сердца, в том числе 63 (6,9%) пациентам со злокачественными новообразованиями сердца различного вида и локализации. Результаты. Операции выполнены 62 больным, из них у 51 (82,3%) - с использованием искусственного кровообращения. Госпитальная летальность при хирургическом лечении злокачественных опухолей сердца составила 22,6% (умерли 14 больных). У 20 (32,3%) больных, которым выполнены условно радикальные кардиохирургические вмешательства с использованием искусственного кровообращения, отмечен хороший гемодинамический эффект. Выводы. Для достижения условной радикальности операции и максимального гемодинамического эффекта в целом ряде наблюдений необходимо применение расширенных методик реконструкции поврежденных структур сердца в сочетании с активной дезинтоксикационной терапией и безотлогательной химиотерапией.
- 30 January 2019
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 85 (1) , 17-20
Open AccessВопросы радикальности хирургического лечения злокачественных опухолей сердца
Цель. Определить методы диагностики и хирургического лечения, направленные на максимально радикальное удаление злокачественной опухоли сердца. Материалы и методы. В Институте сердечно-сосудистой хирургии имени Н. М. Амосова НАМН Украины с 1970 по 01.01.2018 г. проведено лечение 912 пациентам с опухолями сердца, в том числе 63 (6,9%) пациентам со злокачественными новообразованиями сердца различного вида и локализации. Результаты. Операции выполнены 62 больным, из них у 51 (82,3%) - с использованием искусственного кровообращения. Госпитальная летальность при хирургическом лечении злокачественных опухолей сердца составила 22,6% (умерли 14 больных). У 20 (32,3%) больных, которым выполнены условно радикальные кардиохирургические вмешательства с использованием искусственного кровообращения, отмечен хороший гемодинамический эффект. Выводы. Для достижения условной радикальности операции и максимального гемодинамического эффекта в целом ряде наблюдений необходимо применение расширенных методик реконструкции поврежденных структур сердца в сочетании с активной дезинтоксикационной терапией и безотлогательной химиотерапией.